Vellky JE, Kirkpatrick BJ, Gutgesell LC, Morales M, et al. ERBB3 overexpression is enriched in diverse patient populations with castration-sensitive prostate cancer and is associated with a unique AR activity signature. Clin Cancer Res 2024 Feb 2. doi: 10.1158/1078-0432.CCR-23-2161.
PMID: 38306015